The Patent Finder

Biosensors and Methods for Determining Analyte Concentration in the Kinetic Potential Region of Redox Mediators

Pacific Diabetes Technologies Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,216,074Biosensors and Methods for Determining Analyte Concentration in the Kinetic Potential Region of Redox Mediators
In force
 · High confidence
UsedRemaining
Pacific Diabetes Technologies, Inc.In forceHigh confidence
Application 19/012,059Biosensors and Methods for Determining Analyte Concentration in the Kinetic Potential Region of Redox Mediators with Single-Point Calibration
Pending
Not granted
Pacific Diabetes Technologies, Inc.PendingNot granted
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Pacific Diabetes Technologies Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited